Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus.

about

Pharmacokinetics, pharmacodynamics, short term efficacy and safety of RCT-18, a novel BLyS/APRIL fusion protein, in patients with rheumatoid arthritis.

P2860

Q37030677-FBF6BFCD-B185-409F-BFBA-BE8B7007AE6A

P2860

Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus.

Item

http://www.wikidata.org/entity/Q40883706

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Pharmacokinetics, Pharmacodyna ...... Systemic Lupus Erythematosus.

@en

type

Item

label

Pharmacokinetics, Pharmacodyna ...... Systemic Lupus Erythematosus.

@en

prefLabel

Pharmacokinetics, Pharmacodyna ...... Systemic Lupus Erythematosus.

@en

P1476

Pharmacokinetics, Pharmacodyna ...... Systemic Lupus Erythematosus.

@en

P2093

Fengchun Zhang

http://www.w3.org/2001/XMLSchema#string

Ji Jiang

http://www.w3.org/2001/XMLSchema#string

Jianmin Fang

http://www.w3.org/2001/XMLSchema#string

Lin Li

http://www.w3.org/2001/XMLSchema#string

Pei Hu

http://www.w3.org/2001/XMLSchema#string

Qian Zhao

http://www.w3.org/2001/XMLSchema#string

Wen Zhong

http://www.w3.org/2001/XMLSchema#string

Wenxiang Wang

http://www.w3.org/2001/XMLSchema#string

Xia Chen

http://www.w3.org/2001/XMLSchema#string

Xuejing Yao

http://www.w3.org/2001/XMLSchema#string

P2860

BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Targeting B cells with biologics in systemic lupus erythematosus.

Treatment of systemic lupus erythematosus patients with the BAFF antagonist "peptibody" blisibimod (AMG 623/A-623): results from randomized, double-blind phase 1a and phase 1b trials.

Atacicept in combination with MMF and corticosteroids in lupus nephritis: results of a prematurely terminated trial.

B cell receptor signaling in human systemic lupus erythematosus.

Biologic activity and safety of belimumab, a neutralizing anti-B-lymphocyte stimulator (BLyS) monoclonal antibody: a phase I trial in patients with systemic lupus erythematosus

Efficacy of abatacept for arthritis in patients with an overlap syndrome between rheumatoid arthritis and systemic lupus erythematosus.

The immunological basis of B-cell therapy in systemic lupus erythematosus.

P304

948-959

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JCPH.686

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26634642

http://www.w3.org/2001/XMLSchema#string

Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus.

about

P2860

P2860

Pharmacokinetics, Pharmacodynamics, Safety, and Clinical Activity of Multiple Doses of RCT-18 in Chinese Patients With Systemic Lupus Erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698